Attached files
| file | filename |
|---|---|
| EX-5.1 - EXHIBIT 5.1 - Osmotica Pharmaceuticals plc | tm2024554d4_ex5-1.htm |
| EX-1.1 - EXHIBIT 1.1 - Osmotica Pharmaceuticals plc | tm2024554d4_ex1-1.htm |
| 8-K - FORM 8-K - Osmotica Pharmaceuticals plc | tm2024554-4_8k.htm |
Exhibit 99.1
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 14. Other Expenses of Issuance and Distribution.
Set forth below is an estimate (except in the case of the registration fee and FINRA fee) of the amount of fees and expenses to be incurred in connection with the issuance and distribution of the offered securities registered hereby, incurred in connection with the sale of the Company’s ordinary shares. All such amounts will be borne by Osmotica Pharmaceuticals plc.
| FINRA filing fee | $ | 76,708 | |||
| Legal fees and expenses | $ | 500,000 | |||
| Accounting fees and expenses | $ | 111,275 | |||
| Printing expenses | $ | 25,000 | |||
| Total | $ | 712,983 |